Based on initial detection in two index cases with RET fusions (RASGEF1A-RET and NCOA4-RET), 9693 breast cancers were evaluated for the presence of RET rearrangements as well as missense mutations and copy number changes. The gene discussed is NCOA4; the disease is breast carcinoma.